MedWatch·Industry news·Hearing aids·3d agoDemant product stands out in new market analysisStrong investor-driven preference data for the Oticon Zeal signals meaningful competitive pressure in the premium hearing aid segment that clinic owners and dispensers should monitor when making stocking decisions.
MedWatch·Financial report·Business & finance·3d agoBarclays warns that hearing aid market's comeback could be short-livedA potential softening of the premium hearing aid market could pressure clinic revenue, shift patient mix toward lower-cost devices, and affect manufacturer R&D investment across the field.＋Save
